Endocrine crosstalk between muscle and bone

Current Osteoporosis Reports

Volumn 12, Issue 2, 2014, Pages 135-141

  Brotto, Marco ^a   Johnson, Mark L ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone; Endocrine; Muscle; Myokines; Osteokines

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 15; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MYOSTATIN; OSTEOCALCIN; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; VITAMIN D; CYTOKINE;

BONE; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; EVIDENCE BASED MEDICINE; FRACTURE HEALING; GENE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MEF2C GENE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MSTN GENE; MUSCLE; NONHUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PLEIOTROPY; POPULATION GENETICS; REVIEW; SARCOPENIA; SINGLE GENE DISORDER; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

BONE AND BONES; CYTOKINES; HUMANS; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 84904195059     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-014-0209-0     Document Type: Review

References (96)

1. Pourquié O. Vertebrate Somitogenesis. Annu Rev Cell Dev Biol. 2001;17:311-50. (Pubitemid 33096179)
2. Rauch F, Schoenau E. The developing bone: slave or master of its cells and molecules? Pediatr Res. 2001;50:309-14. (Pubitemid 32801953)
3. Land C, Schoenau E. Fetal and postnatal bone development: reviewing the role of mechanical stimuli and nutrition. Best Pract Res Clin Endocrinol Metab. 2008;22:107-18. (Pubitemid 351218279)
4. Gunter KB, Almstedt HC, Janz KF. Physical activity in childhood may be the key to optimizing lifespan skeletal health. Exerc Sport Sci Rev. 2012;40:13-21. doi:10.1097/JES.1090b1013e318236e318235ee.
5. Recker R, Lappe J, Davies K, Heaney R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res. 2000;15:1965-73.
6. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013;75:503-33.
7. Kurek JB et al. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve. 1997;20:815-22. (Pubitemid 27250667)
8. Allen DL et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab. 2008;294:E918-27.
9. •• Pedersen BK. Muscle as a secretory organ. Compr Physiol. 2013;3:1337-62. The discovery of Myostatin as the first muscle secreted factor was a landmark in the fields of muscle and musculoskeletal research. This discovery opened the door for the thinking that secreted factors from muscles could have organismal effects. Also, myostatin became known as the most important negative regulator of muscle mass.
10. Allen DL, Hittel DS, McPherron AC. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc. 2011;43:1828-35.
11. Pedersen BK et al. Searching for the exercise factor: is IL-6 a candidate. J Muscle Res Cell Motil. 2003;24:113-9. (Pubitemid 37323614)
12. Reihmane D, Jurka A, Tretjakos P, Dela F. Increase in IL-6, TNF-a, and MMP-9, but not sICAM-1, concentrations depends on exercise duration. Eur J Appl Physiol. 2013;113:851-88.
13. Libardi CA, De Souza GV, Cavaglieri CR, Madruga VA, Chacon-Mikahil MP. Effect of resistance, endurance, and concurrent training on TNF-a, IL-6, and CRP. Med Sci Sports Exerc. 2012;44:50-5.
14. Matthews VB et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52:1409-18.
15. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol. 2007;103(3):1093-8. (Pubitemid 47358897)
16. Pedersen L, Olsen CH, Pedersen BK, Hojman P. Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle. Am J Physiol Endocrinol Metab. 2012;302:E831-40.
17. Seale P et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. 2008;454:961-7.
18. • Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argiles JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009;296:E191-202. The demonstration that the overexpression of a muscle specific myokine could alter adiposity and also increase BMD is a remarkable indication that muscle can signal to bone in a biochemical manner.
19. Hee Park K et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899-907.
20. Bortoluzzi S, Scannapieco P, Cestaro A, Danieli GA, Schiaffino S. Computational reconstruction of the human skeletal muscle secretome. Proteins. 2006;62:776-92. (Pubitemid 43191263)
21. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457-65.
22. Lee NK et al. Endocrine Regulation of Energy Metabolism by the Skeleton. Cell. 2007;130:456-69. (Pubitemid 47208519)
23. Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metabol. 2008;19:161-6. (Pubitemid 351847838)
24. DiGirolamo DJ, Clemens TL, Kousteni S. The skeleton as an endocrine organ. Nat Rev Rheumatol. 2012;8:674-83.
25. Guntar AR, Rosen CJ. Bone as an Endocrine Organ. Endocr Pract. 2012;18:758-62.
26. Schaffler M, Kennedy O. Osteocyte signaling in bone. Curr Osteoporos Rep. 2012;10:118-25.
27. Schwetz V, Pieber T, Obermayer-Pietsch B. Mechanisms in endocrinology: the endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol. 2012;166:959-67.
28. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481:314-20.
29. Quarles LD. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol. 2012;8:276-86.
30. Neve A, Corrado A, Cantatore FP. Osteocytes: central conductors of bone biology in normal and pathological conditions. Acta Physiol. 2012;204:317-30.
31. Econs MJ et al. A PHEX Gene mutation is responsible for adult-onset Vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-Linked Hypophosphatemic Rickets. J Clin Endocrinol Metab. 1998;83:3459-62. (Pubitemid 28500871)
32. Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell. ... and more. Endocr Rev. 2013;34:658-90.
33. The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345-8.
34. Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab. 2003;285:E1-9. (Pubitemid 36736355)
35. Liu S et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006;291:E38-49. (Pubitemid 44035308)
36. Francis F et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet. 1995;11:130-6.
37. Rowe PSN et al. Distribution of Mutations in the PEX Gene in Families with X-linked Hypophosphataemic Rickets (HYP). Hum Molec Genet. 1997;6:539-49. (Pubitemid 27142102)
38. Dixon PH et al. Mutational analysis of PHEX gene in X-Linked Hypophosphatemia. J Clin Endocrinol Metab. 1998;83:3615-23. (Pubitemid 28500899)
39. Faul C et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121:4393-408.
40. Touchberry CD et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab. 2013;304:E863-73.
41. Winkler DG et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003;22:6267-76. (Pubitemid 37522584)
42. Frost HM. Bone's Mechanostat: a 2003 update. Anat Rec. 2003;275A:1081-101. (Pubitemid 37486785)
43. Arden NK, Spector TD. Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res. 1997;12:2076-81. (Pubitemid 27524484)
44. Silventoinen K, Magnusson PKE, Tynelius P, Kaprio J, Rasmussen F. Heritability of body size andmuscle strength in young adulthood: a study of one million Swedish men. Genet Epidemiol. 2008;32:341-9. (Pubitemid 351656305)
45. Prior SJ et al. Genetic and environmental influences on skeletal muscle phenotypes as a function of age and sex in large, multigenerational families of African heritage. J Appl Physiol. 2007;103:1121-7. (Pubitemid 47605944)
46. Costa A et al. Genetic inheritance effects on endurance and muscle strength. Sports Med. 2012;42:449-58.
47. Rivadeneira F et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009;41:1199-206.
48. Karasik D et al. Genome-wide pleiotropy of osteoporosis-related phenotypes: The Framingham study. J Bone Miner Res. 2010;25:1555-63.
49. Duncan EL et al. Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 2011;7:e1001372.
50. Estrada K et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012;44:491-501.
51. Lee Y, Choi S, Ji J, Song G. Pathway analysis of genome-wide association study for bone mineral density. Mol Biol Rep. 2012;39:8099-106.
52. Ran S et al. Bivariate genome-wide association analyses identified genes with pleiotropic effects for femoral neck bone geometry and age at menarche. PLoS One. 2013;8:e60362.
53. Savage SA et al. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet. 2013;45:799-803.
54. Zhang L, et al. Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet. 2014;23(7):1923-33. doi:10.1093/hmg/ddt575.
55. Oei L, et al. A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus. J Med Genet. 2014;51(2):122-31. doi: 10.1136/jmedgenet-2013-102064.
56. Pérusse L et al. The Human gene map for performance and health-related fitness phenotypes: the 2002 Update. Med Sci Sports Exerc. 2003;35:1248-64. (Pubitemid 36936141)
57. Liu X-G et al. Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. Am J Hum Genet. 2009;84:418-23.
58. Thomis MA et al. Genome-wide linkage scan for resistance to muscle fatigue. Scand J Med Sci Sports. 2011;21:580-8.
59. Windelinckx A et al. Comprehensive fine mapping of chr12q12-14 and follow-up replication identify activin receptor 1B (ACVR1B) as a muscle strength gene. Eur J Hum Genet. 2011;19:208-15.
60. Hai R et al. Genome-wide association study of copy number variation identified gremlin1 as a candidate gene for lean body mass. J Hum Genet. 2012;57:33-7.
61. Kuo T et al. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc Natl Acad Sci. 2012;109:11160-5.
62. Guo Y-F et al. Suggestion of GLYAT gene underlying variation of bone size and body lean mass as revealed by a bivariate genome-wide association study. Hum Genet. 2013;132:189-99.
63. Cheng Y et al. Body composition and gene expression QTL mapping inmice reveals imprinting and interaction effects. BMC Genet. 2013;14:103.
64. Keildson S, et al. Skeletal muscle expression of phosphofructokinase is influenced by genetic variation and associated with insulin sensitivity. Diabetes. 2014;63(3):1154-65. doi:10.2337/db13-1301.
65. Karasik D et al. Bivariate genome-wide linkage analysis of femoral bone traits and leg lean mass: The Framingham Study. J Bone Miner Res. 2009;24:710-8.
66. Karasik D, Kiel DP. Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone. 2010;46:1226-37.
67. Gupta M et al. Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations. J Bone Miner Res. 2011;26:1261-71.
68. Sun L et al. Bivariate genome-wide association analyses of femoral neck bone geometry and appendicular lean mass. PLoS One. 2011;6:e27325.
69. Karasik D, Cohen-Zinder M. Osteoporosis genetics: year 2011 in review. Bone Key Rep. 2012;1(114):1-5.
70. Edmondson DG, Lyons GE, Martin JF, Olson EN. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 1994;120:1251-63. (Pubitemid 24150050)
71. Kramer I, Baertschi S, Halleux C, Keller H, Kneissel M. Mef2c deletion in osteocytes results in increased bone mass. J Bone Miner Res. 2012;27:360-73.
72. Grobet L et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet. 1997;17:71-4. (Pubitemid 27377534)
73. Kambadur R, Sharma M, Smith TPL, Bass JJ. Mutations in myostatin (GDF8) in Double-Muscled Belgian Blue and Piedmontese Cattle. Genome Res. 1997;7:910-5.
74. McPherron AC, Lee S-J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci. 1997;94:12457-61. (Pubitemid 27492550)
75. Clop A et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet. 2006;38:813-8. (Pubitemid 43980603)
76. Mosher DS et al. Amutation in themyostatin gene increases muscle mass and enhances racing performance in Heterozygote Dogs. PLoS Genet. 2007;3:e79.
77. Zhang GX, Zhao XH, Wang JY, Ding FX, Zhang L. Effect of an exon 1 mutation in the myostatin gene on the growth traits of the Bian chicken. Anim Genet. 2012;43:458-9.
78. Williams M. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;351:1030-1. (Pubitemid 39166269)
79. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457-65.
80. Elkasrawy M, Hamrick M. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010;10:56-63.
81. Williams NG et al. Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis. Endocrinology. 2011;152:172-80.
82. Perrini S et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol. 2010;205:201-10.
83. Zacks SI, Sheff MF. Periosteal and metaplastic bone formation in mouse minced muscle regeneration. Lab Invest. 1982;46:405-12. (Pubitemid 12156874)
84. Landry PS, Marino AA, Sadasivan KK, Albright JA. Effect of soft-tissue trauma on the early periosteal response of bone to injury. J Trauma. 2000;48:479-83. (Pubitemid 30183111)
85. Utvag SE, Iversen KB, Grundnes O, Reikeras O. Poor muscle coverage delays fracture healing in rats. Acta Orthop Scand. 2002;73:471-4. (Pubitemid 35013416)
86. Stein H et al. The muscle bed-a crucial factor for fracture healing: a physiological concept. Orthopedics. 2002;25:1379-83. (Pubitemid 36040751)
87. Harry LE et al. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J Orthop Res. 2008;26:1238-44.
88. Gopal S, Majumder AG, Knight SL, De Boer P, Smith RM. Fix and Flap: the radical orthopedic and plastic treatment of severe open fractures of the tibia. J Bone Joint Surg (Br). 2000;82:959-66.
89. • Elkasrawy M et al. Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J Histochem Cytochem. 2012;60:22-30. This paper demonstrated that by inhibiting myostatin action early in the process of musculoskeletal injury, healing of both muscle and bone could be improved and accelerated.
90. Schindeler A, Liu R, Little DG. The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation. 2009;77:12-8.
91. Liu R, Schindeler A, Little DG. The potential role of muscle in bone repair. J Musculoskel Neuronal Interact. 2010;10:71-6.
92. Griffin XL, Costa ML, Parsons N, Smith N. Electromagnetic field stimulation for treating delayed union or non-union of long bone fractures in adults. Cochrane Database Syst Rev, 2011;CD008471.
93. Leon-Salas WD et al. A dual mode pulsed electro-magnetic cell stimulator produces acceleration of myogenic differentiation. Recent Pat Biotechnol. 2013;7:71-81.
94. Fakhouri TH, Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among older adults in the United States, 2007-2010. NCHS Data Brief. 2012;(106):1-8.
95. Conboy IM et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760-4. (Pubitemid 40292986)
96. Jahn K et al. Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of beta-catenin. Eur Cell Mater. 2012;24:197-209. discussion 209-110.